Atlas Trials

Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

Clinical trial NCT02584959 · COMPLETED

Trial details

NCT number
NCT02584959
Sponsor
Shire
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hereditary Angioedema (HAE)
Start date
2015-11-01
Primary completion
2017-07-24
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.